BROOKS LAB LIMITED vs CIPLA LTD

A side-by-side comparison of BROOKS LAB LIMITED (BROOKS) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, CIPLA LTD leads BROOKS vs CIPLA on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

7.91
P/E ratio
29.32
1.82
P/B ratio
3.42
0.00%
Dividend yield
0.92%
₹8.34
EPS
₹48.02

Profitability

BROOKS takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.30%
Return on equity
11.60%
21.00%
Return on capital
15.00%
8.00%
EBITDA margin
21.00%
29.07%
Net margin
13.71%

Growth

BROOKS takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.93%
Revenue CAGR (3Y)
7.37%
Profit CAGR (3Y) even
10.88%

Size & financial health

CIPLA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹192 Cr
Market cap
₹1.14L Cr
₹86 Cr
Revenue
₹28,163 Cr
₹25 Cr
Net profit
₹3,862 Cr
0.07
Debt / equity
0.00
BROOKS LAB LIMITED
  • + ["Company is almost debt free.", "Company has delivered good profit growth of 26.6% CAGR over last 5 years"]
  • ["The company has delivered a poor sales growth of 2.11% over past five years.", "Company has a low return on equity of -2.02% over last 3 years.", "Contingent liabilities of Rs.123 Cr.", "Earnings include an other income of Rs.13.0 Cr.", "Promoter holding has decreased over last 3 years: -13.8%"]
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
BROOKS LAB LIMITED full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.